Patient samples were subjected to staining for prostate-specific membrane antigen (PSMA) and EpCAM proteins, commonly expressed on the surface of prostate cancer cells and epithelial cells, respectively (van der Toom et al. 2019). This evidence concerns the gene FOLH1 and prostate carcinoma.